Surgery, Chemotherapy Considered Protective Survival Factors

Surgery, Chemotherapy Considered Protective Survival Factors in Patients With OC, Liver Metastases

Surgery and chemotherapy significantly improved both overall survival (OS) and cancer-specific survival (CSS) in patients with liver metastases originating from ovarian cancer (OC), who generally face a poor prognosis with a 5-year survival rate of less than 30%.

Related Keywords

Lars Neumann , International Classification Of Diseases , Image Credit , End Results , International Classification , Clin Exp ,

© 2025 Vimarsana